Close Menu

consumer genomics

NEW YORK (GenomeWeb) — 23andMe and genealogy site MyHeritage have announced a collaboration under which they will integrate their products, allowing customers to explore their family histories online through both genetic ancestry data and documents.

NEW YORK (GenomeWeb) – Higher-resolution chromosomal microarray analysis may provide a greater diagnostic yield than conventional techniques, but the ability of CMA to identify more variants of unknown or potentially pathogenic significance may be a double-edged sword when it comes to children in

NEW YORK (GenomeWeb) – Ancestry.com is considering expanding its genetic genealogy services to include family health-related information: The Provo, Utah-based online company recently sent out a survey to customers to gauge what kind of family health information might be of greatest interest to t

NEW YORK (GenomeWeb) – 23andMe and Pfizer said today they will launch a joint research project to study genetic factors involved in the onset, progression, severity, and response to treatments for inflammatory bowel disease.

NEW YORK (GenomeWeb) – Genesis Healthcare, a Tokyo-based provider of consumer genomics and clinical tests to the Japanese market, recently moved to the Affymetrix platform to support its offerings.

NEW YORK (GenomeWeb) – The array market seems poised for a number of new product launches in coming years as Affymetrix recently confirmed that it is developing a next-generation instrument platform.

NEW YORK (GenomeWeb) –The US Food and Drug Administration has accepted for review 23andMe's 510(k) application for a single-condition health report, the consumer genomics firm informed customers.

The term 'consumer genomics' may have a catch-all ring to it, but for the time being it means ancestry testing and genetic genealogy, including for companies such as 23andMe, which built its business on relaying both personal health information and ancestral information back to c

Name: Ken Chahine Title: General manager, DNA, Ancestry.com

Name: Spencer Wells Title: Director of National Geographic's Genographic Project

Pages

The head of Operation Warp Speed tells Bloomberg he expects the paused AstraZeneca and Johnson & Johnson vaccine trials to resume soon.

A new UK government says socioeconomic factors, not genetics, account for disparities in deaths due to COVID-19 between ethnic groups, the Financial Times reports.

NPR reports on an Alzheimer's disease drug trial that is continuing despite the pandemic.

In Nature this week: CRISPR-Cas3 system for making large deletions efficiently, more.